10/06/2026
Innovation, science, and regenerative excellence continue to define the Geneviv Clinic journey.🤍🧬
We are honored that our abstract, “Painless Novel Approach to Tissue Regeneration for Severe Skin Laxity,” has been selected for E-poster presentation at AMWC Korea 2026, one of the world’s leading congresses in aesthetic and anti-aging medicine.
This recognition follows an exceptional year for Geneviv Clinic, including being named among the Top 5 Global Aesthetic Disruptors at AMWC Monaco 2026 for Innovation and receiving the Leading Innovator in Longevity & Personalized Medicine Award from Global Pharma.
At Geneviv, we are committed to challenging conventional medicine by developing regenerative solutions that achieve results once believed to require needles, heat-based treatments, or surgery. Our novel approach demonstrates the potential for meaningful tissue regeneration and skin rejuvenation without needles, without heat, without pain, and without downtime.
We are grateful to AMWC Korea, AMWC Monaco, Global Pharma, our patients, and our international collaborators for supporting our vision of advancing the future of regenerative and longevity medicine.
The future of medicine is regenerative. The future of longevity is innovation.